FDA lifts par­tial hold on Avid­i­ty’s my­oton­ic dy­s­tro­phy drug; Orum's IPO in South Ko­rea

Plus, news about Cali­way Phar­ma­ceu­ti­cals, ar­genx, Halozyme Ther­a­peu­tics, Ver­ri­ca, Liq­uidia and Phar­mosa:

FDA lifts par­tial clin­i­cal hold on Avid­i­ty Bio­sciences’ drug:

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER